Manufacturer record

Sun Pharma Laboratories Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

10 batches manufactured by Sun Pharma Laboratories Ltd (Sikkim) were declared Not of Standard Quality between February 2021 and April 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

10 records linked to Sun Pharma Laboratories Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
10Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2021 to Apr 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

10
NSQ batches since 2021
8
Products affected
Assay
Most common failure
Apr 2024
Latest alert

Flagged batches per year

2021 · 32022 · 22023 · 32024 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Rifaximin Tablets (Rifagut 400) GKE0938 AMfg 2023-06 · Exp 2025-05 Not applicableOther Not applicableState lab Apr 2024
Levetiracetam Tablets IP (Levipil 500) SIE1003AMfg 2023-04 · Exp 2025-03 DissolutionDissolution CDL KolkataCDSCO lab Jan 2024
Rosuvastatin Tablets IP (Rosuvas 10 Tablets) SID3056AMfg 2022-11 · Exp 2025-04 Description and Assay of Rosuvastatin Calcium calculated as RosuvastatinAssay RDTL ChandigarhState lab Jul 2023
Montek LC (Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP) SIC3283AMfg 2021-12 · Exp 2024-05 Identification & Assay of Montelukast Sodium & Assay of Levocetirizine HydrochlorideAssay CDL KolkataCDSCO lab Feb 2023
Pan -D (Pantoprazole Gastro-Resistant and Domperidone Prolonged Release Capsules IP) 22442611Mfg 2022-09 · Exp 2024-08 Identification and AssayAssay CDL KolkataCDSCO lab Jan 2023
Montek� LC (Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP) SIC1932AMfg 2021-08 · Exp 2024-01 Identification and Assay of MontelukastAssay RDTL GuwahatiState lab Oct 2022
Pantoprazole Gastro Resistant and Domperidone Prolonged-Release Capsules IP RPB0651AMfg 2021-01 · Exp 2022-12 Identification and AssayAssay RDTL GuwahatiState lab Apr 2022
Rosuvas� F-5 (Rosuvastatin and Fenofibrate Tablets I.P.) EMU2687Mfg 2019-09 · Exp 2022-02 Dissolution of FenofibrateDissolution CDL KolkataCDSCO lab May 2021
Rosuvas 20 (Rosuvastatin Tablets I.P.) EMX0685Mfg 2020-03 · Exp 2023-08 Dissolution & AssayAssay CDL KolkataCDSCO lab May 2021
Rosuvas 20 (Rosuvastatin Tablets I.P.) EMX0174Mfg 2020-01 · Exp 2022-06 Uniformity of Weight, Dissolution and AssayAssay CDL KolkataCDSCO lab Feb 2021

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.